Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1208.50Today’s High
1244.0052W low
708.8052W High
1292.10Open Price
1216.00Prev. Close
1251.3000Volume
881947.00Value
1092644138.30Fundamentals
Market Cap Cr
72591.90
Price to Earnings
22.90
Price to Book Value
2.40
Dividend Yield
0.40
PE to Growth
0.40
Op Revenue TTM Cr
29001.87
Net Profit TTM Cr
3172.97
Cash From Operating Activity Cr
2434.52
Return on Equity %
10.63
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
02 Jul, 2024
47.3
Week
69
Month
53.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1212.33
PIVOT
First Resistance
1221.67
Second Resistance
1230.28
Third Resistance
1239.62
First Support
1203.72
Second Support
1194.38
Third Support
1185.77
Relative Strength Index
49.59
Money Flow Index
21.33
MACD
2.37
MACD Signal
9.42
Average True Range
33.1
Average Directional Index
23.5
Rate of Change (21)
2.31
Rate of Change (125)
11.9
Commodity Channel Index
-63.1
Williams %R
-62.5
BETA
1 Month
0.71
3 Month
0.64
1 Year
0.64
3 Year
0.26
PRICE CHANGE ANALYSIS
↑ 1.72%
1 Week
Low
High
1180.1
1244
↑ 4.49%
1 Month
Low
High
1109.45
1292.1
↑ 12.48%
3 Months
Low
High
1069.3
1292.1
↑ 13.46%
6 Months
Low
High
958.5
1292.1
↑ 70.33%
1 Year
Low
High
708.85
1292.1
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 3017.00 | 3023.16 | 2735.84 | 2485.70 | 3835.61 | 3510.99 | 3081.52 | 2825.63 | 3300.54 | 2754.34 | 2965.55 | |
| Operating Expenses Qtr | 2119.24 | 2210.34 | 2123.58 | 1968.44 | 2855.61 | 2959.04 | 2729.76 | 2544.66 | 2380.20 | 2407.14 | 2543.45 | |
| Operating Profit Qtr | 774.79 | 481.69 | 545.18 | 422.38 | 691.83 | 473.22 | 295.90 | 242.26 | 506.97 | 215.91 | 339.73 | |
| EBIDT Qtr Cr | 897.76 | 812.82 | 648.35 | 517.26 | 980.00 | 551.95 | 351.76 | 280.97 | 845.63 | 347.20 | 422.10 | |
| Depreciation Qtr | 64.81 | 64.35 | 65.79 | 59.63 | 115.00 | 108.50 | 108.80 | 103.05 | 101.22 | 101.20 | 98.18 | |
| Net Profit Qtr | 578.67 | 623.78 | 415.74 | 335.95 | 644.80 | 298.82 | 164.63 | 122.16 | 802.16 | 239.81 | 197.68 | |
| Basic EPS Qtr | 9.88 | 10.65 | 7.10 | 5.73 | 11.00 | 5.10 | 2.81 | 2.08 | 13.69 | 4.09 | 3.37 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 11261.70 | 13226.04 | 11958.13 | 16413.54 | 13669.85 | |
| Operating Expenses Annual Cr | 8421.60 | 11061.36 | 9813.74 | 11703.85 | 10580.73 | |
| Operating Profit Annual | 2224.04 | 1730.92 | 1473.40 | 4119.83 | 2685.75 | |
| Operating Profit Margin Annual % | 19.75 | 13.09 | 12.32 | 25.10 | 19.65 | |
| Total Expenses Annual Cr | 8858.78 | 11611.69 | 10245.94 | 12220.53 | 11292.15 | |
| EBIDT Annual Cr | 2840.10 | 2164.68 | 2144.39 | 4709.69 | 3089.12 | |
| EBIDT Annual margin % | 25.22 | 16.37 | 17.93 | 28.69 | 22.60 | |
| Depreciation | 254.58 | 435.35 | 415.26 | 488.00 | 470.48 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1900.10 | 1230.41 | 1454.71 | 3112.91 | 1872.74 | |
| Net Profit Annual | 1954.14 | 1230.41 | 1454.71 | 3112.91 | 1872.74 | |
| Basic EPS Annual | 33.35 | 21.00 | 24.83 | 53.13 | 31.96 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 19722.82 | 17914.17 | 17117.34 | 15924.61 | 13025.56 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 186.42 | 346.13 | 302.64 | 507.80 | 149.11 | |
| Total Current Liabilities Annual Cr | 5244.74 | 6673.35 | 4180.97 | 6756.58 | 6359.90 | |
| Total Capital Plus Liabilities Annual Cr | 25153.98 | 24933.65 | 21600.95 | 23188.99 | 19534.57 | |
| Fixed Assets Annual | 2551.81 | 3926.59 | 3810.98 | 5206.96 | 5091.31 | |
| Total Non Current Assets Annual | 17914.85 | 15210.01 | 11765.84 | 10811.13 | 8286.48 | |
| Total Current Assets Annual | 7239.13 | 9723.64 | 9835.11 | 12377.86 | 11248.09 | |
| Total Assets Annual | 25153.98 | 24933.65 | 21600.95 | 23188.99 | 19534.57 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 596.69 | 277.61 | 1337.36 | 2174.36 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1714.80 | 1821.16 | 3726.71 | 2994.41 | 2161.73 | |
| Cash from Investing Activity Annual | -159.96 | -3459.68 | -1613.51 | -2648.73 | -921.57 | |
| Cash from Financing Annual Activity | -1837.03 | 1719.48 | -2447.54 | -27.94 | -1252.39 | |
| Net Cash Flow Annual | - | 80.96 | -334.34 | 317.74 | -12.23 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 336.62 | 305.75 | 292.15 | 271.80 | 222.32 | |
| ROE Annual % | 9.90 | 6.86 | 8.49 | 19.54 | 14.37 | |
| ROCE Annual % | 12.98 | 9.47 | 9.92 | 25.69 | 19.87 | |
| Total Debt to Total Equity Annual | 0.14 | 0.23 | 0.11 | 0.25 | 0.29 | |
| EBDIT Annual Margin % | 26.67 | 16.92 | 18.99 | 29.76 | 23.28 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 7715.77 | 7514.30 | 7406.40 | 6966.85 | 6607.87 | 6499.78 | 5796.56 | 6276.54 | 5858.25 | 6067.21 | 6038.50 | |
| Operating Expenses Qtr | 5907.34 | 5750.47 | 5845.98 | 5699.15 | 5470.78 | 5452.72 | 4948.58 | 5299.44 | 4834.97 | 4985.95 | 4755.20 | |
| Operating Profit Qtr | 1672.81 | 1601.31 | 1373.44 | 1151.37 | 1002.18 | 954.41 | 790.79 | 936.48 | 974.40 | 1016.27 | 1186.72 | |
| EBIDT Qtr Cr | 1686.32 | 1763.83 | 1560.42 | 1197.95 | 1137.09 | 1047.06 | 847.98 | 977.10 | 860.52 | 1116.05 | 1283.30 | |
| Depreciation Qtr | 354.33 | 423.27 | 417.50 | 326.56 | 345.57 | 321.40 | 298.10 | 279.51 | 253.57 | 299.05 | 294.21 | |
| Net Profit Qtr | 908.75 | 936.29 | 757.18 | 570.75 | 506.27 | 491.26 | 409.45 | 520.54 | 576.46 | 604.73 | 696.99 | |
| Basic EPS Qtr | 15.51 | 16.04 | 12.83 | 9.74 | 8.64 | 8.38 | 6.99 | 8.88 | 9.84 | 10.32 | 11.89 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 29559.25 | 25145.97 | 23775.84 | 25155.47 | 23290.38 | |
| Operating Expenses Annual Cr | 23158.87 | 21136.74 | 19068.72 | 19441.22 | 18234.20 | |
| Operating Profit Annual | 5843.00 | 3718.64 | 4386.77 | 5333.40 | 4864.31 | |
| Operating Profit Margin Annual % | 19.77 | 14.79 | 18.45 | 21.20 | 20.89 | |
| Total Expenses Annual Cr | 24970.24 | 22521.80 | 20243.88 | 20571.10 | 19506.04 | |
| EBIDT Annual Cr | 6400.38 | 4009.23 | 4707.12 | 5714.25 | 5056.18 | |
| EBIDT Annual margin % | 21.65 | 15.94 | 19.80 | 22.72 | 21.71 | |
| Depreciation | 1521.66 | 1244.58 | 1126.52 | 1055.39 | 966.71 | |
| PAT Before ExtraOrdinary Items Annual Cr | 3186.13 | 1939.32 | 2678.36 | 5389.18 | 2844.69 | |
| Net Profit Annual | 3172.97 | 1927.50 | 2648.15 | 5334.84 | 2830.97 | |
| Basic EPS Annual | 54.16 | 32.90 | 45.19 | 91.05 | 48.32 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 29842.80 | 26839.85 | 24575.98 | 21929.87 | 16810.38 | |
| Minority Interest Liability Annual Cr | 8.00 | 12.00 | -1.93 | -0.88 | 0.14 | |
| Total Non Current Liabilities Annual Cr | 3021.58 | 1544.36 | 1191.69 | 1259.85 | 729.08 | |
| Total Current Liabilities Annual Cr | 12199.13 | 11493.78 | 8155.98 | 10665.15 | 11386.75 | |
| Total Capital Plus Liabilities Annual Cr | 45071.51 | 39889.99 | 33921.72 | 33853.99 | 28926.35 | |
| Fixed Assets Annual | 17766.36 | 15817.63 | 13803.87 | 12006.21 | 10466.47 | |
| Total Non Current Assets Annual | 20865.88 | 18344.32 | 15799.03 | 14030.48 | 12513.85 | |
| Total Current Assets Annual | 24205.63 | 21545.67 | 18122.69 | 19823.51 | 16412.50 | |
| Total Assets Annual | 45071.51 | 39889.99 | 33921.72 | 33853.99 | 28926.35 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 1813.21 | 1145.45 | 1083.17 | 659.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 2434.52 | 2386.75 | 5016.48 | 3328.92 | 4381.28 | |
| Cash from Investing Activity Annual | -4255.95 | -3977.75 | -3211.56 | 598.69 | -1567.64 | |
| Cash from Financing Annual Activity | 800.42 | 1814.41 | -2969.27 | -1364.81 | -1947.18 | |
| Net Cash Flow Annual | - | 223.41 | -1164.35 | 2562.80 | 866.46 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 509.49 | 458.30 | 419.42 | 374.28 | 286.92 | |
| ROE Annual % | 10.63 | 7.18 | 10.77 | 24.32 | 16.84 | |
| ROCE Annual % | 14.84 | 9.73 | 13.89 | 20.09 | 23.31 | |
| Total Debt to Total Equity Annual | 0.21 | 0.18 | 0.10 | 0.23 | 0.32 | |
| EBDIT Annual Margin % | 22.06 | 16.13 | 20.06 | 23.06 | 21.88 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC MUTUAL FUND | 3.78 | 73809846 | - | - |
| ICICI PRUDENTIAL MUTUAL FUND | 3.6 | 73809847 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| K NITYANANDA REDDY | 4.33 | 73809827 | 42.98 | 0 |
| KIRTHI REDDY KAMBAM | 3.49 | 73809828 | 17.36 | 0 |
| M SIVAKUMARAN | 2.47 | 73809829 | 0 | 0 |
| KAMBAM SPOORTHI | 1.19 | 73809830 | 5.71 | 0 |
| RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING) | 33.51 | 73809838 | 23.81 | 0 |
| AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING) | 2.85 | 73809839 | 0 | 0 |
| VENKATA RAMPRASAD REDDY PENAKA | 3.07 | 73809843 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC MUTUAL FUND | 3.78 | 73809846 |
| ICICI PRUDENTIAL MUTUAL FUND | 3.6 | 73809847 |
| MIRAE ASSET LARGE CAP FUND | 2.84 | 73809848 |
| QUANT MUTUAL FUND | 2.54 | 73809849 |
| LIFE INSURANCE CORPORATION OF INDIA | 3.38 | 73809851 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 20, 2024 | 1.5 | INTERIM | Feb 20, 2024 | Equity Share |
| Nov 20, 2023 | 3 | INTERIM | Nov 20, 2023 | Equity Share |
| Feb 17, 2023 | 3 | INTERIM | Feb 17, 2023 | Equity Share |
| Jun 06, 2022 | 4.5 | INTERIM | Jun 07, 2022 | Equity Share |
| Feb 18, 2022 | 1.5 | INTERIM | Feb 21, 2022 | Equity Share |
| Nov 17, 2021 | 1.5 | INTERIM | Nov 18, 2021 | Equity Share |
| Aug 27, 2021 | 1.5 | INTERIM | Aug 30, 2021 | Equity Share |
| Feb 22, 2021 | 1.5 | INTERIM | Feb 23, 2021 | Equity Share |
| Nov 23, 2020 | 1.25 | INTERIM | Nov 24, 2020 | Equity Share |
| Aug 21, 2020 | 1.25 | INTERIM | - | Equity Share |
| Feb 17, 2020 | 1.75 | INTERIM | Feb 18, 2020 | Equity Share |
| Nov 21, 2019 | 1.25 | INTERIM | Nov 23, 2019 | Equity Share |
| Feb 15, 2019 | 1.25 | INTERIM | Feb 19, 2019 | Equity Share |
| Nov 20, 2018 | 1.25 | INTERIM | Nov 22, 2018 | Equity Share |
| Feb 20, 2018 | 1 | INTERIM | Feb 21, 2018 | Equity Share |
| Nov 21, 2017 | 1.5 | INTERIM | Nov 22, 2017 | Equity Share |
| Jun 08, 2017 | 1.25 | INTERIM | Jun 09, 2017 | Equity Share |
| Nov 24, 2016 | 1.25 | INTERIM | Nov 25, 2016 | Equity Share |
| Jun 09, 2016 | 0.7 | INTERIM | Jun 10, 2016 | Equity Share |
| Feb 18, 2016 | 0.7 | INTERIM | Feb 22, 2016 | Equity Share |
| Nov 19, 2015 | 0.6 | INTERIM | Nov 20, 2015 | Equity Share |
| Aug 21, 2015 | 0.5 | INTERIM | - | Equity Share |
| Jun 08, 2015 | 1 | INTERIM | Jun 09, 2015 | Equity Share |
| Feb 16, 2015 | 2 | INTERIM | Feb 18, 2015 | Equity Share |
| Aug 13, 2014 | 1.5 | INTERIM | - | Equity Share |
| Jun 11, 2014 | 1.75 | INTERIM | Jun 12, 2014 | Equity Share |
| Nov 19, 2013 | 1.25 | INTERIM | Nov 20, 2013 | Equity Share |
| Jul 30, 2013 | 0.5 | FINAL | - | Equity Share |
| Feb 18, 2013 | 1 | INTERIM | Feb 20, 2013 | Equity Share |
| Jul 30, 2012 | 1 | FINAL | - | Equity Share |
| Jul 20, 2011 | 1 | FINAL | - | Equity Share |
| Nov 11, 2010 | 5 | INTERIM | Nov 12, 2010 | Equity Share |
| Sep 13, 2010 | 2 | FINAL | - | Equity Share |
| Feb 05, 2010 | 3 | INTERIM | Feb 08, 2010 | Equity Share |
| Dec 16, 2009 | 1.5 | FINAL | - | Equity Share |
| Feb 05, 2009 | 3 | INTERIM | Feb 06, 2009 | Equity Share |
| Aug 11, 2008 | 3.25 | FINAL | - | Equity Share |
| Sep 14, 2007 | 2.5 | FINAL | - | Equity Share |
| Sep 08, 2006 | 1.5 | FINAL | - | Equity Share |
| Sep 20, 2005 | 0.5 | FINAL | - | Equity Share |
| Jul 22, 2004 | 2.25 | FINAL | - | Equity Share |
| Sep 08, 2003 | 3.5 | FINAL | - | Equity Share |
| Sep 19, 2002 | 3 | FINAL | - | Equity Share |
| Sep 12, 2001 | - | FINAL | - | Equity Share |
| May 10, 2000 | - | INTERIM | May 25, 2000 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Feb 10, 2011 | 5:1 | 2011-02-11 |
| Oct 23, 2003 | 10:5 | 2003-10-31 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 25, 2024 | Audited Results | - |
| Feb 10, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 09, 2023 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2023 | Quarterly Results | - |
| May 27, 2023 | Audited Results | - |
| Feb 09, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2022 | Quarterly Results | - |
| Aug 11, 2022 | Quarterly Results | - |
| May 30, 2022 | Audited Results & 4th Interim Dividend | - |
| Feb 09, 2022 | Quarterly Results & 3rd Interim Dividend | - |
| Nov 08, 2021 | Quarterly Results & 2nd Interim Dividend | - |
| Aug 12, 2021 | Quarterly Results & Interim Dividend | - |
| May 31, 2021 | Audited Results | - |
| Feb 10, 2021 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2020 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2020 | Quarterly Results & Interim Dividend | - |
| Jun 03, 2020 | Audited Results | - |
| Feb 06, 2020 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2019 | Quarterly Results & Interim Dividend | - |
| Aug 07, 2019 | Quarterly Results | - |
| May 28, 2019 | Audited Results | - |
| Feb 07, 2019 | Quarterly Results & 2nd Interim Dividend | - |
| Nov 12, 2018 | Quarterly Results & Interim Dividend | - |
| Aug 09, 2018 | Unaudited Financial Results | - |
| May 28, 2018 | Audited Results | - |
| Feb 07, 2018 | Quarterly Results & 2nd Interim Dividend | - |
| Nov 09, 2017 | Quarterly Results & Interim Dividend | - |
| Aug 09, 2017 | Quarterly Results | - |
| May 29, 2017 | Audited Results & Dividend | - |
| Feb 09, 2017 | Quarterly Results | - |
| Nov 14, 2016 | Quarterly Results & Interim Dividend | - |
| Aug 23, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results & Dividend | Appointed Mr. B. Adi Reddy as the Company Secretary & Compliance Officer of the Company with effect from June 01, 2016. |
| Feb 09, 2016 | Quarterly Results & 3rd Interim Dividend | - |
| Nov 06, 2015 | Raising of Funds | Raising of funds through issue of securities. |
| Aug 12, 2015 | Quarterly Results & Interim Dividend | - |
| May 28, 2015 | Audited Results & Dividend | To considered and recommended for issue of ONE bonus equity share for every ONE equity share held as on a Record Date to be determined. |
| Feb 04, 2015 | Quarterly Results & 2nd Interim Dividend | - |
| Nov 25, 2014 | To consider raising of funds | Inter alia, consider raising of funds through issue of securities. |
| Nov 06, 2014 | Quarterly Results | - |
| Aug 07, 2014 | Interim Dividend | - |
| May 30, 2014 | Audited Results & Dividend | Final Dividend & Second Interim Dividend |
| Feb 06, 2014 | Quarterly Results | - |
| Nov 07, 2013 | Quarterly Results & Interim Dividend | - |
| Aug 09, 2013 | Quarterly Results | - |
| May 30, 2013 | Audited Results & Final Dividend | - |
| Feb 07, 2013 | Quarterly Results & Interim Dividend | - |
| Nov 09, 2012 | Quarterly Results | - |
| Aug 07, 2012 | Quarterly Results | - |
| May 29, 2012 | Audited Results & Dividend | - |
| Feb 13, 2012 | Quarterly Results | (Revised) |
| Jan 18, 2012 | Appointment of Additional Director | The Board has appointed Dr. C Channa Reddy as an Additional Director of the Company, He will function as a Non Executive, Independent Director of the Company. |
| Nov 08, 2011 | Quarterly Results | - |
| Aug 06, 2011 | Quarterly Results | - |
| May 09, 2011 | Audited Results & Final Dividend | - |
| Feb 05, 2011 | Quarterly Results | - |
| Nov 03, 2010 | Interim Dividend & Stock split | The Board has approved the sub-division of Equity Shares of the face value of Rs. 5/- each in the Company into Equity Shares of the face value of Re. 1/- each. |
| Aug 05, 2010 | Quarterly Results | - |
| May 29, 2010 | Audited Results & Final Dividend | - |
| Jan 30, 2010 | Quarterly Results & Interim Dividend | The Board has approved payment of an Interim Dividend @ 60% i.e. Rs. 3/- per Equity Share of Rs. 5/- each to the members of the Company for the Current Financial Year 2009-2010. |
| Nov 12, 2009 | Audited Results, Dividend & Others | To consider the draft of Scheme of Amalgamation for the Merger of Trident Life Sciences Ltd being WoS of the Co., with itself & all the assets & liabilities of Trident shall be transfered. |
| Oct 30, 2009 | Quarterly Results | - |
| Aug 14, 2009 | Acquisition of Stake | The Board has approved the proposal to acquire 100% stake of Trident Life Sciences Ltd, ("TLSL") subject to suitable agreements being executed between the parties for the same. |
| Jul 31, 2009 | Quarterly Results | - |
| Apr 30, 2009 | Quarterly Results | - |
| Mar 31, 2009 | Scheme of Arrangement | To approve the SoA, which provides the followings 1. Utilization of the Capital Redemption Reserve Account of Rs 90.0 million outstanding as on March 31, 2008 & 2. The gains arising on the buyback. |
| Jan 30, 2009 | Quarterly Results & Interim Dividend | - |
| Oct 31, 2008 | Quarterly Results | - |
| Jul 30, 2008 | Quarterly Results | - |
| Jun 18, 2008 | Audited Results & Dividend | - |
| Jan 30, 2008 | Quarterly Results | - |
| Oct 31, 2007 | Quarterly Results | - |
| Jul 31, 2007 | Quarterly Results | - |
| Jun 30, 2007 | Audited Results & Dividend | - |
| Jan 31, 2007 | Quarterly Results | - |
| Dec 15, 2006 | Merger & ESOP | Inter alia, to consider the proposal for merger of APL Life Sciences Ltd & Senor Organics Pvt Ltd, the wholly owned subsidiary Companies of the Company, with itself. |
| Nov 14, 2006 | To acquire M/s. Senor Organics | To acquire M/s. Senor Organics Pvt Ltd, a profit making, small size pharma Company based at Hyderabad. |
| Oct 30, 2006 | Quarterly Results | - |
| Jul 31, 2006 | Quarterly Results | - |
| Jun 27, 2006 | Accounts & Dividend | - |
| Apr 01, 2006 | To consider issue of FCCBs | To consider a proposal for issue of Foreign Currency Convertible Bonds (FCCBs) or other equity or equity linked securities in the overseas markets. |
| Oct 31, 2005 | Quarterly Results | - |
| Jul 30, 2005 | Quarterly Results | - |
| Jun 30, 2005 | Accounts, Dividend & Others | To consider a proposal for issue of Foreign Currency Convertible Bonds or such other similar securities in the Overseas markets. |
| Jan 15, 2005 | Quarterly Results | - |
| Oct 29, 2004 | Quarterly Results | - |
| Jul 31, 2004 | Quarterly Results | - |
| Jun 02, 2004 | Dividend & Accounts | - |
| Feb 18, 2004 | Others | To consider the allotment of equity shares of Rs 5/- each of the company to Merlion India Fund Ltd & also to appoint the nominee of Merlion on the Board of Directors of the company |
| Jan 31, 2004 | Quarterly Results | - |
| Nov 29, 2003 | Others | To issue further shares of the company on private placement/preferential allotment basis. |
| Oct 31, 2003 | Quarterly Results | - |
| Aug 09, 2003 | Sub Division of Equity shares | - |
| Jul 31, 2003 | Quarterly Results | - |
| Jun 30, 2003 | Accounts & Dividend | - |
| Jan 31, 2003 | Quarterly Results | - |
| Nov 15, 2002 | Others | Amalgamation of Ranit Pharma Ltd. and Calac Pvt. Ltd. with the company |
| Oct 31, 2002 | Quarterly Results & Half Yearly Results | - |
| Sep 27, 2002 | Others | Issue of equity shares on conversion of share warrants which were issued to promoters/directors and Templeton STrategic Emerging Markets Fund LDC |
| Jun 30, 2002 | Accounts & Dividend | - |
| Apr 14, 2002 | Others | Allotment of 10,00,000 equity shares & 10,00,000 Warrants to Templeton Emerging Markets Funds LDC. |
| Mar 27, 2002 | Others | To allot further equity shares/warrants to the promoters to the extent of receipt of subscriptions from them pursuant to the Special Resolution passed in the EGM held on 15-1-2002. |
| Mar 11, 2002 | Revocation of Interim Dividend | To consider the Revocation of Interim Dividend declared for the financial year 2001-2002. |
| Mar 08, 2002 | Interim Dividend | - |
| Jan 31, 2002 | Quarterly Results | - |
| Dec 14, 2001 | Private Placement | To issue further shares, convertible debentures or share warrants or such other instruments as the Board think fit, on private placement basis. (Revised) |
| Oct 31, 2001 | Quarterly Results | - |
| Jul 31, 2001 | Quarterly Results | - |
| Jun 29, 2001 | Accounts & Dividend | - |
| Jan 31, 2001 | Quarterly Results | - |
| Oct 31, 2000 | Amalgamation & Quarterly Results | amalgamation of Sri Chakra Remedies Ltd. with the company and Quarterly Results |
| Aug 28, 2000 | Preferential Allotment & Right Issue of Eq. Shares | - |
| Jul 31, 2000 | Quarterly Results | - |
| May 27, 2000 | Accounts | - |
| Mar 27, 2000 | Interim dividend | - |
| Jan 22, 2000 | Quarterly Results & Bonus issue | - |
| Oct 30, 1999 | Quarterly Results | - |
| Jul 21, 1999 | Quarterly Results | - |
| May 15, 1999 | Accounts, Dividend | - |
| Jan 30, 1999 | Quarterly Results | - |
| Oct 27, 1998 | Quarterly Results | - |
| Dec 26, 1997 | Private Placement | - |
| Nov 15, 1997 | Half Yearly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jul 20, 2015 | 1:1 | 2015-07-21 |
| Mar 07, 2000 | 1:1 | 2000-04-01 |
28 Jun 2024
Aurobindo Pharma Unit Acquires Ace Laboratories For Rs 18 Crore
The company was acquired for nearly Rs 18 crore on a debt-free basis.
28 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation of acquisition of entire share capital of Ace Laboratories Limited, UK by Agile Pharma B.V., The Netherlands, a wholly owned step-down subsidiary of the Company for a consideration of INR 17.91 Crore on debt free basis.
27 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Classification Of US FDA Inspection At The Injectable Facility Of Eugia SEZ Pvt. Ltd.
Intimation of classification of US FDA inspection at the injectable facility of Eugia SEZ Pvt. Ltd., a wholly owned step- down subsidiary of the Company.
26 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Closure of Trading Window
Intimation of closure of trading window for dealing in shares of the Company in connection with the declaration of unaudited financial results for the quarter ending on June 30, 2024.
14 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of letters of credit in lieu of lost share certificates.
12 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kirthi Reddy Kambam
10 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investors meet scheduled on June 13, 2024.
06 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on June 11, 2024.
06 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on June 10, 2024.
06 Jun 2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on 18.06.2024.
